iohexol has been researched along with Acute Kidney Failure in 146 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigated the effect and mechanism of rosiglitazone on a rat model with contrast-induced acute kidney injury (CI-AKI)." | 9.51 | Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPAR ( Chen, E; Huang, J; Wu, J; Zheng, X, 2022) |
| "Edaravone was administered for two weeks before the induction of CI-AKI." | 5.72 | Exploring the effects of edaravone in rats with contrast-induced acute kidney injury. ( Al Tahrawi, AY; Alshogran, OY; Nusair, SD, 2022) |
| "Iohexol was used to act on HK-2 cells to establish a renal tubular cell pyroptosis model; and the signal pathway genes were silenced, cytokines were detected by enzyme-linked immunosorbent assay (ELISA), and cell viability, gene expression, and protein expression were evaluated by double fluorescence staining and flow cytometry." | 5.72 | Baicalin Alleviates Contrast-Induced Acute Kidney Injury Through ROS/NLRP3/Caspase-1/GSDMD Pathway-Mediated Proptosis in vitro. ( Huang, D; Li, Y; Wang, J; Yu, C, 2022) |
| "This study investigated the effect and mechanism of rosiglitazone on a rat model with contrast-induced acute kidney injury (CI-AKI)." | 5.51 | Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPAR ( Chen, E; Huang, J; Wu, J; Zheng, X, 2022) |
| " Two children (2/42) had decreased cyst C eGFR, for one of whom iohexol clearance confirmed mildly decreased GFR." | 4.31 | Kidney outcomes in early adolescence following perinatal asphyxia and hypothermia-treated hypoxic-ischaemic encephalopathy. ( Bárány, P; Blennow, M; Chromek, M; Diaz Ruiz, S; Kublickiene, K; Robertsson Grossmann, K; Vishnevskaya, L, 2023) |
| " Possible reasons for the diverse impact of blood pressure on the propensity to develop acute kidney failure after iodine-based but not gadolinium-based enhancement imaging are discussed." | 3.91 | Negligible Risk of Acute Renal Failure Among Hospitalized Patients After Contrast-Enhanced Imaging With Iodinated Versus Gadolinium-Based Agents. ( Gorelik, Y; Heyman, SN; Khamaisi, M; Yaseen, H, 2019) |
| " In our study, dehydration duration and the iohexol dosage were found to be the two most important factors to develop a rat CIN model." | 3.91 | A novel rat model of contrast-induced nephropathy based on dehydration. ( Chen, LH; Cheng, WJ; Hu, C; Li, DY; Liu, K; Wang, JL; Xie, YL; Yin, WJ; Zhou, G; Zhou, LY; Zuo, SR; Zuo, XC, 2019) |
| "Kidney Disease: Improved Global Outcomes acute kidney injury criteria were fulfilled in 22 patients (nephrectomy = 5, surgery = 4, and acute kidney injury = 13); continuous infusion of low-dose Iohexol demonstrated acute kidney injury in 29 patients (nephrectomy = 10, surgery = 8, acute kidney injury = 11)." | 3.88 | Continuous Infusion of Low-Dose Iohexol Measures Changing Glomerular Filtration Rate in Critically Ill Patients. ( Chis Ster, I; Dalton, RN; Dixon, JJ; Lane, K; MacPhee, IAM; Philips, BJ; Turner, C, 2018) |
| "The study was processed to investigate the effect of astaxanthin (AST; 3,3-dihydroxybeta, beta-carotene-4,4-dione) on the acute kidney injury induced by iohexol and the relationship with SIRT1/FOXO3a signal pathway." | 3.88 | Astaxanthin attenuates contrast agent-induced acute kidney injury in vitro and in vivo via the regulation of SIRT1/FOXO3a expression. ( Chen, J; Gao, D; Li, W; Liu, N; Zheng, D, 2018) |
| "The application of iodinated contrast medium has become a risk factor for metformin-associated lactic acidosis (MALA), which leads to the accumulation of metformin in vivo is one of the principal reasons for MALA." | 3.88 | Involvement of organic cation transporter 2 in the metformin-associated increased lactate levels caused by contrast-induced nephropathy. ( Dai, Y; Huo, X; Liu, K; Liu, Z; Ma, X; Meng, Q; Peng, J; Sun, H; Wang, C; Yang, S, 2018) |
| "Rats received nitric oxide synthase inhibitor L-NAME (10 mg/kg) and cyclooxygenase inhibitor indomethacin (10 mg/kg) to induce the risk for developing iodinated contrast-induced acute kidney injury before receiving one of the interventions: NAC, furosemide, or placebo." | 3.80 | Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker. ( Franklin, T; Li, LP; Lu, J; Papadopoulou, MV; Prasad, PV; Solomon, R; Thacker, J; Zhou, Y, 2014) |
| "Contrast induced acute kidney injury is one of the most frequent causes of hospital acquired acute kidney injury." | 2.77 | Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial. ( Binder, C; Jaberi, A; Kitzler, TM; Kotanko, P; Petnehazy, E; Rehak, P; Sendlhofer, G; Stacher, R, 2012) |
| " The secondary endpoints are absolute and relative increases in sCr of at least 50%, thrombolysis in myocardial infarction (TIMI) perfusion grade, and major adverse cardiac events at 1, 6, and 12 months." | 2.75 | The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study. ( Angioli, P; Bolognese, L; Carrera, A; Ducci, K; Falsini, G; Grotti, S; Liistro, F; Limbruno, U; Picchi, A; Pierli, C, 2010) |
| "Eighty-two patients with chronic renal failure, referred for coronary angiography, were assigned randomly to receive either normal saline intravenously and prophylactic hemodialysis (dialysis group; n = 42) or fluid supplement only (control group; n = 40)." | 2.73 | Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. ( Chen, CL; Chou, KJ; Chung, HM; Fang, HC; Hsu, CY; Lee, PT; Liu, CP; Mar, GY, 2007) |
| "Iodixanol was cost-effective compared with iohexol, with both lower costs and better effects related to fewer adverse drug reactions." | 2.71 | Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy. ( Aspelin, P; Aubry, P; Fransson, SG; Lundkvist, J; Strasser, R; Willenbrock, R, 2005) |
| " Clinically severe adverse renal events were uncommon (N = 15) and did not differ in incidence between contrast groups (iohexol N = 6; diatrizoate N = 9)." | 2.68 | Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. ( Cohen, MB; Goldfarb, S; Halpern, EF; Hill, JA; Ludbrook, PA; Murphy, MJ; Rudnick, MR; VanFossen, DB; Wexler, L; Winniford, M, 1995) |
| "Pretreatment with nitrendipine did not reduce enzyme excretion, although AAP levels were lower in general in the group assigned to the 20-mg dose." | 2.68 | Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. ( Artero, M; Carraro, M; Cova, M; Faccini, L; Grotto, M; Mancini, W; Stacul, F, 1996) |
| "Theophylline levels were within the therapeutic range in patients of the theophylline group during and four hours after CM application (59." | 2.67 | Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. ( Bohle, A; Duda, SH; Erley, CM; Huppert, PE; Koehler, J; Osswald, H; Risler, T; Schlepckow, S; Strohmaier, WL, 1994) |
| "Contrast media can cause acute renal failure by direct toxic effects on the tubular cells and kidney ischemia." | 2.48 | Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy. ( Chicaíza-Becerra, LA; Gamboa, Ó; García-Molina, M, 2012) |
| "Iohexol and ox-LDL were used alone or in combination to treat HK-2 cells." | 1.91 | Ox-LDL aggravates contrast-induced injury of renal tubular epithelial cells. ( Chen, S; Lv, M; Tan, J; Yang, D; Yang, X, 2023) |
| " Compared to the control, rats that received vancomycin had numerically lower GFRs after drug dosing on day 3." | 1.91 | Iohexol-Measured Glomerular Filtration Rate and Urinary Biomarker Changes between Vancomycin and Vancomycin Plus Piperacillin-Tazobactam in a Translational Rat Model. ( Barreto, EF; Chang, J; Lesnicki, E; Marianski, S; Pais, GM; Scheetz, MH; Valdez, K, 2023) |
| "Edaravone was administered for two weeks before the induction of CI-AKI." | 1.72 | Exploring the effects of edaravone in rats with contrast-induced acute kidney injury. ( Al Tahrawi, AY; Alshogran, OY; Nusair, SD, 2022) |
| "Iohexol was used to act on HK-2 cells to establish a renal tubular cell pyroptosis model; and the signal pathway genes were silenced, cytokines were detected by enzyme-linked immunosorbent assay (ELISA), and cell viability, gene expression, and protein expression were evaluated by double fluorescence staining and flow cytometry." | 1.72 | Baicalin Alleviates Contrast-Induced Acute Kidney Injury Through ROS/NLRP3/Caspase-1/GSDMD Pathway-Mediated Proptosis in vitro. ( Huang, D; Li, Y; Wang, J; Yu, C, 2022) |
| "Contrast-induced acute kidney injury is a prevalent cause of renal failure, and the noninvasive tools to monitor its progress are lacking." | 1.48 | Application of noninvasive functional imaging to monitor the progressive changes in kidney diffusion and perfusion in contrast-induced acute kidney injury rats at 3.0 T. ( Chen, W; Dong, Y; Guo, B; Lian, Z; Liu, J; Ouyang, F; Zhang, B; Zhang, S, 2018) |
| "A total of 2563 patients diagnosed with STEMI and underwent primary pPCI were retrospectively included in the study." | 1.46 | Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. ( Akdeniz, E; Alper, AT; Bozbay, M; Eren, M; Gumusdag, A; Guvenc, TS; Guzelburc, O; Hayiroglu, MI; Kalenderoglu, K; Oz, A; Tanik, O; Tekkesin, AI; Ugur, M; Velibey, Y, 2017) |
| "Inclusion criteria were STEMI patients taken for cardiac catheterization, excluding patients receiving hemodialysis due to end-stage renal disease (ESRD)." | 1.43 | The incidence and significance of acute kidney injury following emergent contrast administration in patients with STEMI and stroke. ( Allen, BR; Elie, MC; Marchick, MR; Shuster, JJ; Weeks, EC, 2016) |
| "Contrast-induced acute renal injury (CI-AKI) has become a common cause of hospital-acquired renal failure." | 1.43 | Salvianolic Acid B Prevents Iodinated Contrast Media-Induced Acute Renal Injury in Rats via the PI3K/Akt/Nrf2 Pathway. ( Jiachang, H; Nana, S; Shaopeng, L; Ting, Z; Tongqiang, L; Xialian, X; Xiaofang, Y; Xiaoqiang, D, 2016) |
| " ARF was induced by the subcutaneous administration of cisplatin (5 mg/kg); IoCl and InCl were determined simultaneously, and plasma creatinine (pCreat) dosage was measured colorimetrically." | 1.42 | Iohexol clearance for determination of glomerular filtration rate in rats induced to acute renal failure. ( Câmara, NO; Mastroianni-Kirsztajn, G; Nishida, SK; Passos, MT; Shimizu, MH, 2015) |
| "More necrosis was present after incubation with iohexol and iopamidol than after incubation with equal concentrations of iodixanol." | 1.40 | Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury. ( Cafiero, C; Gesualdo, L; Grandaliano, G; Montemurno, E; Netti, GS; Prattichizzo, C; Ranieri, E; Rascio, F; Simone, S; Stallone, G, 2014) |
| "Atorvastatin (ATO) was administered intragastrically at the dose of 5, 10 and 30mg/kg/d in different groups, respectively, for 5 days before iopromide injection." | 1.40 | Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of Rho-kinase pathway. ( Cai, W; Cao, Y; Chen, X; Li, S; Ma, W; Su, J; Wang, F; Zou, W, 2014) |
| "In patients with liver cirrhosis a urine protein:creatinine ratio >30 predicts AKI." | 1.39 | Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers. ( Auzinger, G; Bernal, W; Bruce, M; Dew, T; Heneghan, MA; McPhail, MJ; Moore, K; Musto, R; O'Grady, J; Ostermann, M; Sherwood, R; Slack, AJ; Wendon, JA, 2013) |
| "upon iodixanol injection was reduced almost to the level of iopromide when injecting iodixanol/mannitol (iopromide: 289 ± 68 HU vs iodixanol/mannitol: 343 ± 68 HU)." | 1.38 | The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety. ( Ellinghaus, P; Ernst, R; Jost, G; Lengsfeld, P; Lenhard, DC; Pietsch, H; Sieber, MA, 2012) |
| "The odds ratio of acute kidney failure on day 5 was 0." | 1.38 | Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease. ( Ghahramani, N; Lapsiwala, A; Parhizgar, A; Saadulla, L; Spatz, C, 2012) |
| "Most patients with HCC have coexisting liver cirrhosis (LC) at the time of diagnosis." | 1.37 | Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. ( Bae, EJ; Chang, SH; Cho, HS; Kang, Y; Kim, HJ; Park, DJ; Seo, JW, 2011) |
| "Postoperative acute renal failure (ARF) is not uncommon after cardiac surgery and after angiography." | 1.35 | Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. ( Ballotta, A; Bossone, E; Conti, D; De Benedetti, D; Kandil, H; Kunkl, A; Mehta, RH; Mollichelli, N; Ranucci, M, 2008) |
| "The HOCM, diatrizoate, was more toxic to rat kidneys than the LOCM iohexol; PLA2, LPO and calcium load played a role in producing renal function impairment induced by diatrizoate meglumine; amlodipine protected the renal tissue from nephrotoxicity induced by diatrizoate." | 1.31 | Nephrotoxicity of high- and low-osmolar contrast media. The protective role of amlodipine in a rat model. ( Duan, SB; Liu, FY; Liu, RH; Luo, JA; Peng, YM; Wu, HW; Yang, XL, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (2.05) | 18.7374 |
| 1990's | 14 (9.59) | 18.2507 |
| 2000's | 27 (18.49) | 29.6817 |
| 2010's | 79 (54.11) | 24.3611 |
| 2020's | 23 (15.75) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, L | 2 |
| Huang, S | 2 |
| Zhu, T | 1 |
| Ge, X | 1 |
| Pei, C | 1 |
| Hong, G | 1 |
| Han, L | 1 |
| Nabi, MM | 1 |
| Sakamoto, T | 1 |
| Mamun, MA | 1 |
| Islam, A | 1 |
| Waliullah, ASM | 1 |
| Aramaki, S | 1 |
| Hasan, MM | 1 |
| Ema, S | 1 |
| Kato, A | 1 |
| Takahashi, Y | 1 |
| Kahyo, T | 1 |
| Setou, M | 1 |
| Sato, T | 1 |
| Smeets, NJL | 1 |
| Teunissen, EMM | 1 |
| van der Velden, K | 1 |
| van der Burgh, MJP | 1 |
| Linders, DE | 1 |
| Teesselink, E | 1 |
| Moes, DAR | 1 |
| Tøndel, C | 1 |
| Ter Heine, R | 1 |
| van Heijst, A | 1 |
| Schreuder, MF | 1 |
| de Wildt, SN | 1 |
| Wu, J | 2 |
| Shen, J | 1 |
| Wang, W | 1 |
| Jiang, N | 2 |
| Jin, H | 1 |
| Che, X | 1 |
| Ni, Z | 2 |
| Fang, Y | 4 |
| Mou, S | 2 |
| Robertsson Grossmann, K | 1 |
| Vishnevskaya, L | 1 |
| Diaz Ruiz, S | 1 |
| Kublickiene, K | 1 |
| Bárány, P | 1 |
| Blennow, M | 1 |
| Chromek, M | 1 |
| Alshogran, OY | 1 |
| Al Tahrawi, AY | 1 |
| Nusair, SD | 1 |
| Li, Y | 2 |
| Wang, J | 1 |
| Huang, D | 1 |
| Yu, C | 1 |
| Liu, K | 4 |
| Hu, C | 2 |
| Yin, W | 1 |
| Zhou, L | 1 |
| Gu, X | 1 |
| Zuo, X | 1 |
| Huang, J | 1 |
| Chen, E | 2 |
| Zheng, X | 1 |
| Yang, D | 2 |
| Yang, X | 2 |
| Chen, S | 2 |
| Lv, M | 1 |
| Tan, J | 1 |
| Chang, J | 1 |
| Pais, GM | 1 |
| Marianski, S | 1 |
| Valdez, K | 1 |
| Lesnicki, E | 1 |
| Barreto, EF | 1 |
| Scheetz, MH | 1 |
| Chen, HY | 1 |
| Wu, YH | 1 |
| Wei, CY | 1 |
| Liao, ZY | 1 |
| Wu, HT | 1 |
| Chen, YC | 1 |
| Pang, JS | 1 |
| Zhou, LY | 2 |
| Yin, WJ | 2 |
| Xie, YL | 2 |
| Wang, JL | 2 |
| Zuo, SR | 2 |
| Tang, ZY | 1 |
| Wu, YF | 1 |
| Zuo, XC | 2 |
| Kalogirou, TE | 1 |
| Meditskou, S | 1 |
| Davidopoulou, S | 1 |
| Savvas, I | 1 |
| Pitoulias, AG | 1 |
| Pitoulias, GA | 1 |
| Yang, KJ | 1 |
| Kim, JH | 1 |
| Chang, YK | 1 |
| Park, CW | 1 |
| Kim, SY | 1 |
| Hong, YA | 2 |
| Diprose, WK | 1 |
| Sutherland, LJ | 1 |
| Wang, MTM | 1 |
| Barber, PA | 1 |
| Li, DY | 2 |
| Cheng, WJ | 2 |
| Chen, LH | 1 |
| Zhou, G | 1 |
| Lin, HH | 1 |
| Lee, TS | 1 |
| Lin, SJ | 1 |
| Yeh, YC | 1 |
| Lu, TM | 1 |
| Hsu, CP | 1 |
| Chen, F | 1 |
| Lu, J | 3 |
| Xiao, B | 1 |
| Chen, H | 1 |
| Pei, W | 1 |
| Jin, Y | 1 |
| Wang, M | 1 |
| Zhang, J | 1 |
| Liu, F | 1 |
| Gu, G | 1 |
| Cui, W | 1 |
| Liu, C | 1 |
| Hu, YH | 1 |
| Han, Y | 1 |
| Wang, YB | 1 |
| Zhang, Y | 1 |
| Zhang, XQ | 1 |
| He, DF | 1 |
| Ren, HM | 1 |
| Liu, YK | 1 |
| Wang, HY | 1 |
| Tan, T | 1 |
| Lin, PH | 1 |
| Li, HC | 1 |
| Rovin, BH | 1 |
| Ma, JJ | 1 |
| Zeng, CY | 1 |
| Wang, Z | 1 |
| Liu, H | 1 |
| Meng, H | 2 |
| Zhang, D | 1 |
| Xu, J | 1 |
| Ma, L | 1 |
| Fu, P | 1 |
| Suh, K | 1 |
| Kellum, JA | 1 |
| Kane-Gill, SL | 1 |
| Annamalai, C | 1 |
| Seth, R | 1 |
| Viswanathan, P | 1 |
| Desgrouas, M | 1 |
| Merdji, H | 1 |
| Bretagnol, A | 1 |
| Barin-Le Guellec, C | 2 |
| Halimi, JM | 2 |
| Ehrmann, S | 2 |
| Salmon Gandonnière, C | 1 |
| Shibata, S | 1 |
| Moniwa, N | 1 |
| Kuno, A | 1 |
| Kimura, A | 1 |
| Ohwada, W | 1 |
| Sugawara, H | 1 |
| Gocho, Y | 1 |
| Tanaka, M | 1 |
| Yano, T | 1 |
| Furuhashi, M | 1 |
| Tanno, M | 1 |
| Miki, T | 1 |
| Miura, T | 1 |
| Chen, G | 1 |
| Liu, B | 1 |
| Li, H | 2 |
| Liu, J | 3 |
| Mai, Z | 1 |
| Zhou, C | 1 |
| Sun, G | 1 |
| Guo, Z | 1 |
| Lei, L | 1 |
| Zhang, L | 1 |
| Li, M | 1 |
| Tan, N | 2 |
| Liao, Y | 1 |
| Chen, J | 3 |
| Liu, Y | 2 |
| Rowe, ES | 2 |
| Rowe, VD | 2 |
| Hunter, J | 2 |
| Gralinski, MR | 2 |
| Neves, LA | 1 |
| Rollins, K | 1 |
| Noorani, A | 1 |
| Janeckova, L | 1 |
| Jones, T | 1 |
| Griffiths, M | 1 |
| Baker, MP | 1 |
| Boyle, JR | 1 |
| Zhang, B | 1 |
| Dong, Y | 1 |
| Guo, B | 1 |
| Chen, W | 1 |
| Ouyang, F | 1 |
| Lian, Z | 1 |
| Zhang, S | 1 |
| Spasojević-Dimitrijeva, B | 1 |
| Kotur-Stevuljević, J | 1 |
| Đukić, M | 1 |
| Paripović, D | 1 |
| Miloševski-Lomić, G | 1 |
| Spasojević-Kalimanovska, V | 1 |
| Pavićević, P | 1 |
| Mitrović, J | 1 |
| Kostić, M | 1 |
| Takahashi, EA | 1 |
| Kallmes, DF | 6 |
| Fleming, CJ | 1 |
| McDonald, RJ | 6 |
| McKusick, MA | 1 |
| Bjarnason, H | 1 |
| Harmsen, WS | 1 |
| Misra, S | 1 |
| Düzel, B | 1 |
| Emren, SV | 1 |
| Berilgen, R | 1 |
| Hudzik, B | 1 |
| Szkodziński, J | 1 |
| Korzonek-Szlacheta, I | 1 |
| Wilczek, K | 1 |
| Gierlotka, M | 1 |
| Lekston, A | 1 |
| Zubelewicz-Szkodzińska, B | 1 |
| Gąsior, M | 1 |
| Dixon, JJ | 1 |
| Lane, K | 1 |
| Dalton, RN | 1 |
| Turner, C | 1 |
| MacPhee, IAM | 1 |
| Chis Ster, I | 1 |
| Philips, BJ | 1 |
| Jeong, BY | 1 |
| Lee, HY | 1 |
| Park, CG | 1 |
| Kang, J | 1 |
| Yu, SL | 1 |
| Choi, DR | 1 |
| Han, SY | 1 |
| Park, MH | 1 |
| Cho, S | 1 |
| Lee, SY | 1 |
| Hwang, WM | 1 |
| Yun, SR | 1 |
| Ryu, HM | 1 |
| Oh, EJ | 1 |
| Park, SH | 1 |
| Kim, YL | 1 |
| Yoon, SH | 1 |
| Liu, N | 1 |
| Gao, D | 1 |
| Li, W | 2 |
| Zheng, D | 1 |
| Lei, R | 1 |
| Zhao, F | 2 |
| Tang, CY | 2 |
| Luo, M | 2 |
| Yang, SK | 1 |
| Cheng, W | 2 |
| Li, XW | 2 |
| Duan, SB | 3 |
| McDonald, JS | 5 |
| Steckler, EM | 1 |
| Katzberg, RW | 4 |
| Williamson, EE | 5 |
| Cernigliaro, JG | 1 |
| Hamadah, AM | 1 |
| Gharaibeh, K | 1 |
| Leung, N | 1 |
| Tran, CL | 1 |
| Kolbe, AB | 1 |
| Mukherjee, D | 1 |
| Nedungadi, S | 1 |
| Yang, S | 1 |
| Dai, Y | 1 |
| Liu, Z | 1 |
| Wang, C | 1 |
| Meng, Q | 1 |
| Huo, X | 1 |
| Sun, H | 1 |
| Ma, X | 1 |
| Peng, J | 1 |
| Azzalini, L | 1 |
| Vilca, LM | 1 |
| Lombardo, F | 1 |
| Poletti, E | 1 |
| Laricchia, A | 1 |
| Beneduce, A | 1 |
| Maccagni, D | 1 |
| Demir, OM | 1 |
| Slavich, M | 1 |
| Giannini, F | 1 |
| Carlino, M | 2 |
| Margonato, A | 1 |
| Cappelletti, A | 1 |
| Colombo, A | 2 |
| Zhang, Z | 1 |
| Shao, X | 1 |
| Gu, L | 1 |
| Li, S | 2 |
| Lin, Q | 1 |
| He, Y | 1 |
| Zhang, M | 1 |
| Zhou, W | 1 |
| McCullough, PA | 2 |
| Todoran, TM | 1 |
| Brilakis, ES | 1 |
| Ryan, MP | 1 |
| Gunnarsson, C | 1 |
| Gorelik, Y | 1 |
| Yaseen, H | 1 |
| Heyman, SN | 1 |
| Khamaisi, M | 1 |
| Ravn, B | 1 |
| Rimes-Stigare, C | 1 |
| Bell, M | 1 |
| Hansson, M | 1 |
| Hansson, LO | 1 |
| Martling, CR | 1 |
| Larsson, A | 1 |
| Mårtensson, J | 1 |
| Hu, Z | 1 |
| Shang, T | 1 |
| Huang, R | 1 |
| Li, Q | 1 |
| Zheng, P | 1 |
| Wang, H | 1 |
| Xie, P | 1 |
| Slack, AJ | 1 |
| McPhail, MJ | 1 |
| Ostermann, M | 1 |
| Bruce, M | 1 |
| Sherwood, R | 1 |
| Musto, R | 1 |
| Dew, T | 1 |
| Auzinger, G | 1 |
| Bernal, W | 1 |
| O'Grady, J | 1 |
| Heneghan, MA | 1 |
| Moore, K | 1 |
| Wendon, JA | 1 |
| Lele, SS | 1 |
| Mukhopadhyay, BN | 1 |
| Mardikar, MM | 1 |
| Patel, TA | 1 |
| Vasavada, AK | 1 |
| Banker, DN | 1 |
| Kapasi, KD | 1 |
| Chauhan, VC | 1 |
| Chawla, KC | 1 |
| Raju, SR | 1 |
| Hiremath, SS | 1 |
| Chinchole, SS | 1 |
| Rajapurkar, MM | 1 |
| Limbruno, U | 3 |
| Picchi, A | 3 |
| Micheli, A | 1 |
| Calabria, P | 1 |
| Cortese, B | 1 |
| Brizi, G | 1 |
| Severi, S | 1 |
| De Caterina, R | 1 |
| Murakami, R | 1 |
| Kumita, S | 1 |
| Hayashi, H | 1 |
| Sugizaki, K | 1 |
| Okazaki, E | 1 |
| Kiriyama, T | 1 |
| Hakozaki, K | 1 |
| Tani, H | 1 |
| Miki, I | 1 |
| Takeda, M | 1 |
| Miao, Y | 1 |
| Zhong, Y | 1 |
| Yan, H | 1 |
| Wang, BY | 1 |
| Jin, J | 1 |
| Netti, GS | 1 |
| Prattichizzo, C | 1 |
| Montemurno, E | 1 |
| Simone, S | 1 |
| Cafiero, C | 1 |
| Rascio, F | 1 |
| Stallone, G | 1 |
| Ranieri, E | 1 |
| Grandaliano, G | 1 |
| Gesualdo, L | 1 |
| Beyazal, H | 1 |
| Caliskan, Z | 1 |
| Utaç, C | 1 |
| Sun, S | 1 |
| Zhang, T | 2 |
| Nie, P | 1 |
| Hu, L | 1 |
| Yu, Y | 1 |
| Cui, M | 1 |
| Cai, Z | 1 |
| Shen, L | 1 |
| He, B | 2 |
| Su, J | 1 |
| Zou, W | 1 |
| Cai, W | 1 |
| Chen, X | 1 |
| Wang, F | 1 |
| Ma, W | 1 |
| Cao, Y | 1 |
| Li, LP | 2 |
| Zhou, Y | 2 |
| Papadopoulou, MV | 2 |
| Franklin, T | 2 |
| Bokhary, U | 1 |
| Solomon, R | 3 |
| Sen, A | 1 |
| Prasad, PV | 2 |
| Li, WH | 1 |
| Qian, WH | 1 |
| Liu, JL | 1 |
| Xu, TD | 1 |
| Zhu, H | 1 |
| He, HY | 1 |
| Thacker, J | 1 |
| Wang, YC | 1 |
| Tang, A | 1 |
| Chang, D | 1 |
| Zhang, SJ | 1 |
| Ju, S | 1 |
| Hwang, YJ | 1 |
| Hyun, MC | 1 |
| Choi, BS | 1 |
| Chun, SY | 1 |
| Cho, MH | 1 |
| Chua, HR | 1 |
| Horrigan, M | 1 |
| Mcintosh, E | 1 |
| Bellomo, R | 1 |
| Carter, RE | 3 |
| Hartman, RP | 3 |
| Mariani, J | 1 |
| Guedes, C | 1 |
| Soares, P | 1 |
| Zalc, S | 1 |
| Campos, CM | 1 |
| Lopes, AC | 1 |
| Spadaro, AG | 1 |
| Perin, MA | 1 |
| Filho, AE | 1 |
| Takimura, CK | 1 |
| Ribeiro, E | 1 |
| Kalil-Filho, R | 1 |
| Edelman, ER | 1 |
| Serruys, PW | 1 |
| Lemos, PA | 1 |
| Liu, T | 2 |
| Liu, S | 1 |
| Yu, X | 1 |
| Zhang, H | 2 |
| Liang, M | 1 |
| Ding, X | 2 |
| Liu, TQ | 1 |
| Luo, WL | 1 |
| Tan, X | 1 |
| Yu, XF | 1 |
| Cai, JR | 1 |
| Ding, XQ | 1 |
| Passos, MT | 1 |
| Nishida, SK | 1 |
| Câmara, NO | 1 |
| Shimizu, MH | 1 |
| Mastroianni-Kirsztajn, G | 1 |
| Liu, YH | 1 |
| Chen, JY | 1 |
| Zhou, YL | 1 |
| Luo, JF | 1 |
| Yu, DQ | 1 |
| Li, LW | 1 |
| Li, HL | 1 |
| Ye, P | 1 |
| Ran, P | 1 |
| Mirrakhimov, AE | 1 |
| Mirrakhimov, EM | 1 |
| Shema-Didi, L | 1 |
| Kristal, B | 1 |
| Eizenberg, S | 1 |
| Marzuq, N | 1 |
| Sussan, M | 1 |
| Feldman-Idov, Y | 1 |
| Ofir, P | 1 |
| Atar, S | 1 |
| Ko, GJ | 1 |
| Bae, SY | 1 |
| Pyo, HJ | 1 |
| Kwon, YJ | 1 |
| Gramberg, MC | 1 |
| Penne, EL | 1 |
| Marchick, MR | 1 |
| Allen, BR | 1 |
| Weeks, EC | 1 |
| Shuster, JJ | 1 |
| Elie, MC | 1 |
| Arayan, A | 1 |
| Nigogosyan, MA | 1 |
| Van Every, MJ | 1 |
| Wu, P | 1 |
| Zhao, Y | 1 |
| Xu, Z | 1 |
| Wang, ZM | 1 |
| Li, C | 1 |
| Yang, Z | 1 |
| Salmon-Gandonnière, C | 1 |
| Benz-de Bretagne, I | 1 |
| Mercier, E | 1 |
| Joret, A | 1 |
| Biswas, S | 1 |
| Mosher, G | 1 |
| Insisienmay, L | 1 |
| Ozias, MK | 1 |
| Barnett, JS | 1 |
| Fananapazir, G | 1 |
| Troppmann, C | 1 |
| Corwin, MT | 1 |
| Nikpour, AM | 1 |
| Naderi, S | 1 |
| Lamba, R | 1 |
| Tongqiang, L | 1 |
| Shaopeng, L | 1 |
| Xiaofang, Y | 1 |
| Nana, S | 1 |
| Xialian, X | 1 |
| Jiachang, H | 1 |
| Ting, Z | 1 |
| Xiaoqiang, D | 1 |
| Velibey, Y | 1 |
| Oz, A | 1 |
| Tanik, O | 1 |
| Guvenc, TS | 1 |
| Kalenderoglu, K | 1 |
| Gumusdag, A | 1 |
| Akdeniz, E | 1 |
| Bozbay, M | 1 |
| Tekkesin, AI | 1 |
| Guzelburc, O | 1 |
| Hayiroglu, MI | 1 |
| Alper, AT | 1 |
| Ugur, M | 1 |
| Eren, M | 1 |
| Sun, SQ | 1 |
| Ding, D | 1 |
| Zhang, WF | 1 |
| Wang, XL | 1 |
| Sun, Z | 1 |
| Hu, LH | 1 |
| Qin, SY | 1 |
| Shen, LH | 1 |
| Goic, JB | 1 |
| Koenigshof, AM | 1 |
| McGuire, LD | 1 |
| Klinger, AC | 1 |
| Beal, MW | 1 |
| Barbieri, L | 1 |
| Verdoia, M | 1 |
| Nardin, M | 1 |
| Marino, P | 1 |
| Suryapranata, H | 1 |
| De Luca, G | 1 |
| Hu, J | 1 |
| Chen, R | 1 |
| Jia, P | 1 |
| Song, N | 1 |
| Xu, X | 1 |
| Ji, J | 1 |
| Kurtul, A | 1 |
| Yarlioglues, M | 1 |
| Duran, M | 1 |
| Matsunami, T | 1 |
| Hino, K | 1 |
| Dosho, R | 1 |
| Miyatake, S | 1 |
| Ebisu, G | 1 |
| Kuwatsuru, R | 1 |
| Nie, B | 1 |
| Li, YF | 1 |
| Cao, Z | 1 |
| Yang, Q | 1 |
| Zhao, YX | 1 |
| Guo, YH | 1 |
| Zhou, YJ | 1 |
| Heinrich, MC | 1 |
| Häberle, L | 1 |
| Müller, V | 1 |
| Bautz, W | 1 |
| Uder, M | 1 |
| Chuang, FR | 1 |
| Chen, TC | 1 |
| Wang, IK | 1 |
| Chuang, CH | 1 |
| Chang, HW | 1 |
| Ting-Yu Chiou, T | 1 |
| Cheng, YF | 1 |
| Lee, WC | 1 |
| Chen, WC | 1 |
| Yang, KD | 1 |
| Lee, CH | 1 |
| Agrawal, V | 1 |
| Swami, A | 1 |
| Kosuri, R | 1 |
| Alsabbagh, M | 1 |
| Agarwal, M | 1 |
| Samarapungavan, D | 1 |
| Rocher, LL | 1 |
| Capasso, P | 1 |
| Weisbord, SD | 1 |
| Vasheghani-Farahani, A | 1 |
| Sadigh, G | 1 |
| Kassaian, SE | 1 |
| Khatami, SM | 1 |
| Fotouhi, A | 1 |
| Razavi, SA | 1 |
| Mansournia, MA | 1 |
| Yamini-Sharif, A | 1 |
| Amirzadegan, A | 1 |
| Salarifar, M | 1 |
| Sadeghian, S | 1 |
| Davoodi, G | 1 |
| Borumand, MA | 1 |
| Esfehani, FA | 1 |
| Darabian, S | 1 |
| Bolognese, L | 2 |
| Falsini, G | 2 |
| Grotti, S | 2 |
| Liistro, F | 2 |
| Carrera, A | 2 |
| Angioli, P | 2 |
| Ducci, K | 2 |
| Pierli, C | 2 |
| Trivedi, H | 1 |
| Foley, WD | 1 |
| Serafin, Z | 1 |
| Karolkiewicz, M | 1 |
| Gruszka, M | 1 |
| Strózecki, P | 1 |
| Lasek, W | 1 |
| Odrowaz-Sypniewska, G | 1 |
| Manitius, J | 1 |
| Beuth, W | 1 |
| Wi, J | 1 |
| Ko, YG | 1 |
| Kim, JS | 1 |
| Kim, BK | 1 |
| Choi, D | 1 |
| Ha, JW | 1 |
| Hong, MK | 1 |
| Jang, Y | 1 |
| Cho, HS | 1 |
| Seo, JW | 1 |
| Kang, Y | 1 |
| Bae, EJ | 1 |
| Kim, HJ | 1 |
| Chang, SH | 1 |
| Park, DJ | 1 |
| Schwenke, C | 1 |
| LaBounty, TM | 1 |
| Shah, M | 1 |
| Raman, SV | 1 |
| Lin, FY | 1 |
| Berman, DS | 1 |
| Min, JK | 1 |
| Kitzler, TM | 1 |
| Jaberi, A | 1 |
| Sendlhofer, G | 1 |
| Rehak, P | 1 |
| Binder, C | 1 |
| Petnehazy, E | 1 |
| Stacher, R | 1 |
| Kotanko, P | 1 |
| Lenhard, DC | 1 |
| Pietsch, H | 1 |
| Sieber, MA | 1 |
| Ernst, R | 1 |
| Lengsfeld, P | 1 |
| Ellinghaus, P | 1 |
| Jost, G | 1 |
| Spatz, C | 1 |
| Saadulla, L | 1 |
| Lapsiwala, A | 1 |
| Parhizgar, A | 1 |
| Ghahramani, N | 1 |
| Chicaíza-Becerra, LA | 1 |
| García-Molina, M | 1 |
| Gamboa, Ó | 1 |
| Ludwig, U | 1 |
| Connemann, J | 1 |
| Keller, F | 1 |
| Emch, TM | 1 |
| Haller, NA | 1 |
| MacNeill, BD | 1 |
| Harding, SA | 1 |
| Bazari, H | 1 |
| Patton, KK | 1 |
| Colon-Hernadez, P | 1 |
| DeJoseph, D | 1 |
| Jang, IK | 1 |
| Rashid, ST | 1 |
| Salman, M | 1 |
| Myint, F | 1 |
| Baker, DM | 1 |
| Agarwal, S | 1 |
| Sweny, P | 1 |
| Hamilton, G | 1 |
| Aspelin, P | 1 |
| Aubry, P | 1 |
| Fransson, SG | 1 |
| Strasser, R | 1 |
| Willenbrock, R | 1 |
| Lundkvist, J | 1 |
| Hsieh, YC | 1 |
| Ting, CT | 1 |
| Liu, TJ | 1 |
| Wang, CL | 1 |
| Chen, YT | 1 |
| Lee, WL | 1 |
| Mueller, C | 1 |
| Seidensticker, P | 1 |
| Buettner, HJ | 1 |
| Perruchoud, AP | 1 |
| Staub, D | 1 |
| Christ, A | 1 |
| Buerkle, G | 1 |
| Briguori, C | 1 |
| Airoldi, F | 1 |
| Morici, N | 1 |
| Sangiorgi, GM | 1 |
| Violante, A | 1 |
| Focaccio, A | 1 |
| Montorfano, M | 1 |
| Condorelli, G | 1 |
| Ricciardelli, B | 1 |
| Kwak, HS | 1 |
| Lee, YH | 1 |
| Han, YM | 1 |
| Jin, GY | 1 |
| Kim, W | 1 |
| Chung, GH | 1 |
| Hocher, B | 1 |
| Lee, HT | 1 |
| Jan, M | 1 |
| Bae, SC | 1 |
| Joo, JD | 1 |
| Goubaeva, FR | 1 |
| Yang, J | 1 |
| Kim, M | 1 |
| Valente, S | 1 |
| Lazzeri, C | 1 |
| Giglioli, C | 1 |
| Margheri, M | 1 |
| Comeglio, M | 1 |
| Nicolaci, L | 1 |
| Chechi, T | 1 |
| Gensini, GF | 1 |
| Poletti, PA | 1 |
| Saudan, P | 1 |
| Platon, A | 1 |
| Mermillod, B | 1 |
| Sautter, AM | 1 |
| Vermeulen, B | 1 |
| Sarasin, FP | 1 |
| Becker, CD | 1 |
| Martin, PY | 1 |
| Lee, PT | 1 |
| Chou, KJ | 1 |
| Liu, CP | 1 |
| Mar, GY | 1 |
| Chen, CL | 1 |
| Hsu, CY | 1 |
| Fang, HC | 1 |
| Chung, HM | 1 |
| Tejedor-Jorge, A | 1 |
| Bouzas-Mosquera, A | 1 |
| Vázquez-Rodríguez, JM | 1 |
| Calviño-Santos, R | 1 |
| Peteiro-Vázquez, J | 1 |
| Flores-Ríos, X | 1 |
| Marzoa-Rivas, R | 1 |
| Piñón-Esteban, P | 1 |
| Aldama-López, G | 1 |
| Salgado-Fernández, J | 1 |
| Vázquez-González, N | 1 |
| Castro-Beiras, A | 1 |
| Möckel, M | 1 |
| Radovic, M | 1 |
| Kühnle, Y | 1 |
| Combé, V | 1 |
| Waigand, J | 1 |
| Schröder, S | 1 |
| Dietz, R | 1 |
| Frei, U | 1 |
| Eckardt, KU | 1 |
| Ranucci, M | 1 |
| Ballotta, A | 1 |
| Kunkl, A | 1 |
| De Benedetti, D | 1 |
| Kandil, H | 1 |
| Conti, D | 1 |
| Mollichelli, N | 1 |
| Bossone, E | 1 |
| Mehta, RH | 1 |
| Wiemer, M | 1 |
| Kreuzpaintner, G | 1 |
| Lauer, B | 1 |
| Kiefel, V | 1 |
| Schultheiss, HP | 1 |
| Horstkotte, D | 1 |
| Strauer, BE | 1 |
| Rudnick, MR | 1 |
| Goldfarb, S | 1 |
| Wexler, L | 1 |
| Ludbrook, PA | 1 |
| Murphy, MJ | 1 |
| Halpern, EF | 1 |
| Hill, JA | 1 |
| Winniford, M | 1 |
| Cohen, MB | 1 |
| VanFossen, DB | 1 |
| Erley, CM | 1 |
| Duda, SH | 1 |
| Schlepckow, S | 1 |
| Koehler, J | 1 |
| Huppert, PE | 1 |
| Strohmaier, WL | 1 |
| Bohle, A | 1 |
| Risler, T | 1 |
| Osswald, H | 1 |
| Touati, C | 1 |
| Idee, JM | 1 |
| Deray, G | 1 |
| Santus, R | 1 |
| Balut, C | 1 |
| Beaufils, H | 1 |
| Jouanneau, C | 1 |
| Bourbouze, R | 1 |
| Doucet, D | 1 |
| Bonnemain, B | 1 |
| Nikonoff, T | 1 |
| Skau, T | 1 |
| Berglund, J | 1 |
| Nyberg, P | 2 |
| Spångberg-Viklund, B | 2 |
| Larsson, R | 2 |
| Carraro, M | 1 |
| Mancini, W | 1 |
| Artero, M | 1 |
| Stacul, F | 1 |
| Grotto, M | 1 |
| Cova, M | 1 |
| Faccini, L | 1 |
| Liss, P | 2 |
| Nygren, A | 2 |
| Erikson, U | 1 |
| Ulfendahl, HR | 1 |
| Liu, FY | 1 |
| Luo, JA | 1 |
| Wu, HW | 1 |
| Liu, RH | 1 |
| Peng, YM | 1 |
| Yang, XL | 1 |
| Thomsen, HS | 1 |
| Pettersson, G | 1 |
| Towart, R | 1 |
| Grant, D | 1 |
| Thyberg, K | 1 |
| Golman, K | 1 |
| Spångberg, A | 1 |
| Tervahartiala, P | 1 |
| Kivisaari, L | 1 |
| Kivisaari, R | 1 |
| Virtanen, I | 1 |
| Standertskjöld-Nordenstam, CG | 1 |
| Love, L | 1 |
| Olson, MC | 1 |
| Parvez, Z | 1 |
| Ramamurthy, S | 1 |
| Patel, NB | 1 |
| Moncada, R | 1 |
| Campbell, DR | 1 |
| Flemming, BK | 1 |
| Mason, WF | 1 |
| Jackson, SA | 1 |
| Hirsch, DJ | 1 |
| MacDonald, KJ | 1 |
| Taliercio, CP | 1 |
| McCallister, SH | 1 |
| Holmes, DR | 1 |
| Ilstrup, DM | 1 |
| Vlietstra, RE | 1 |
| Gomes, AS | 1 |
| Lois, JF | 1 |
| Baker, JD | 1 |
| McGlade, CT | 1 |
| Bunnell, DH | 1 |
| Hartzman, S | 1 |
| Elliott, C | 1 |
| Reger, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study[NCT02050269] | Phase 3 | 100 participants (Actual) | Interventional | 2014-01-31 | Completed | ||
| Contrast-inDuced nephRotoxicity as Assessed by the Cystatin-modified KIdney Load-to-DAmage RElationship[NCT01908309] | Early Phase 1 | 150 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903): A Multicenter, Single-blind, Randomised Controlled Trial[NCT04028323] | Phase 4 | 60 participants (Anticipated) | Interventional | 2019-07-16 | Recruiting | ||
| Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial[NCT05283512] | 254 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
| Renal Insufficiency Following Contrast Media Administration Trial IV: Contrast Media Volume Control for Limiting Contrast-Induced Acute Kidney in Acute Coronary Syndrome.[NCT04714736] | 522 participants (Anticipated) | Interventional | 2020-02-10 | Recruiting | |||
| Minimizing cOntrast utiliZAtion With IVUS Guidance in coRonary angioplasTy: The MOZART Study[NCT01947335] | Phase 4 | 83 participants (Actual) | Interventional | 2012-11-30 | Completed | ||
| IVUS Based Ultra-low Volume Contrast Media PCI to Reduce Contrast Induced Nephrology in Patient With Chronic Kidney disease-a Multi-center, Open Label, Randomized Trial (IVUS-CKD)[NCT05913362] | 320 participants (Anticipated) | Interventional | 2023-10-01 | Not yet recruiting | |||
| Pre-existing Microalbuminuria Predicting Contrast-induced Acute Kidney Injury (CIAKI) Following Coronary Angiography (CAG)[NCT02808845] | 800 participants (Anticipated) | Observational | 2016-12-31 | Not yet recruiting | |||
| Evaluation of Glomerular Filtration Rate Using Iohexol Plasma Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance[NCT04776486] | 90 participants (Anticipated) | Interventional | 2020-09-03 | Recruiting | |||
| Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention[NCT03266458] | 210 participants (Anticipated) | Observational [Patient Registry] | 2018-01-01 | Not yet recruiting | |||
| The Contrast Media and Nephrotoxicity Following Coronary Revascularization by Primary Angioplasty for Acute Myocardial Infarction. The CONTRAST-AMI Study.[NCT00827788] | Phase 4 | 432 participants (Anticipated) | Interventional | 2008-12-31 | Completed | ||
| Department of Geriatrics[NCT02575092] | Phase 2/Phase 3 | 4,000 participants (Actual) | Interventional | 2015-11-01 | Completed | ||
| High Dose Atorvastatin Raises Threshold of Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention[NCT04375787] | Phase 4 | 200 participants (Actual) | Interventional | 2020-03-15 | Completed | ||
| Evaluation of the Effect of Dapagliflozin on Cardiac Remodeling in Post Myocardial Infarction Patients[NCT05335629] | 60 participants (Anticipated) | Interventional | 2022-09-01 | Recruiting | |||
| N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients[NCT00780962] | Phase 2 | 399 participants (Actual) | Interventional | 2007-10-16 | Completed | ||
| PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION[NCT00130598] | Phase 2/Phase 3 | 258 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
| Clinical Controlled Trial to Determinate the Role of Sodium Bicarbonate in the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing to Diagnostic Coronariography and/or Percutaneous Coronary Intervention[NCT00424320] | Phase 3 | 100 participants | Interventional | 2006-10-31 | Recruiting | ||
| BIcarbonato di Sodio e N-Acetilcisteina Nella Prevenzione Della Nefropatia da Mezzo di Contrasto Nell'infaRto mIocardico acutO(Registro BINARIO)[NCT01218178] | 520 participants (Actual) | Observational | 2008-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Increase >= 0.5 mg/dl in basal serum creatinine (NCT01947335)
Timeframe: 7 days
| Intervention | percentage of participants (Number) |
|---|---|
| Angiography-guided PCI | 19 |
| IVUS-guided PCI | 7.3 |
Total volume of iodine contrast administered during the index procedure. (NCT01947335)
Timeframe: Day 1
| Intervention | ml (Median) |
|---|---|
| Angiography-guided PCI | 64.5 |
| IVUS-guided PCI | 20.0 |
Composite of death, myocardial infarction or repeat revascularization (NCT01947335)
Timeframe: 30 days and 6 months
| Intervention | participants (Number) | |
|---|---|---|
| 30 days | 6-months | |
| Angiography-guided PCI | 2 | 2 |
| IVUS-guided PCI | 2 | 5 |
Contrast-induced nephropathy was defined as an increase in serum creatinine level of greater than or equal to 0.5 mg/dL or an increase of 25% above baseline. The primary outcome was measured by the change in serum creatinine level from the pre-radiocontrast baseline to the serum creatinine level measured 48 to 72 hours after radiocontrast administration. (NCT00780962)
Timeframe: 48-72 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| N-Acetycysteine Group | 14 |
| 0.9% Sodium-chloride Group | 12 |
4 reviews available for iohexol and Acute Kidney Failure
| Article | Year |
|---|---|
A systematic review of cost-effectiveness analyses across the acute kidney injury landscape.
Topics: Acute Kidney Injury; Biomarkers; Contrast Media; Cost-Benefit Analysis; Humans; Iohexol; Renal Repla | 2021 |
Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Topics: Acute Kidney Injury; Aged; Cardiac Catheterization; Confidence Intervals; Contrast Media; Creatinine | 2009 |
Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
Topics: Acute Kidney Injury; Aged; Colombia; Contrast Media; Cost-Benefit Analysis; Decision Trees; Drug Cos | 2012 |
The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients.
Topics: Acute Kidney Injury; Contrast Media; Humans; Incidence; Iohexol; Kidney Failure, Chronic; Osmolar Co | 2005 |
26 trials available for iohexol and Acute Kidney Failure
| Article | Year |
|---|---|
Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPAR
Topics: Acute Kidney Injury; Animals; Caspase 3; Creatinine; Furosemide; Interleukin-10; Iohexol; Kidney; Ni | 2022 |
Impact of catalytic iron on mortality in patients with acute coronary syndrome exposed to iodinated radiocontrast-The Iscom Study.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Contrast Media; Creatinine; Female; Follow-Up Studies; | 2013 |
Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Creatinine; Dose-Response Relations | 2014 |
Alprostadil plays a protective role in contrast-induced nephropathy in the elderly.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Alprostadil; Blood Urea Nitrogen; Contras | 2013 |
Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention.
Topics: Acute Kidney Injury; Aged; Alprostadil; Contrast Media; Creatinine; Female; Glomerular Filtration Ra | 2014 |
Acute kidney injury after using contrast during cardiac catheterization in children with heart disease.
Topics: Acute Kidney Injury; Biomarkers; Cardiac Catheterization; Child; Contrast Media; Fatty Acid-Binding | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease | 2014 |
Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Coronary A | 2016 |
A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Contrast Media; | 2008 |
Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
Topics: Acute Kidney Injury; Adult; Aged; Contrast Media; Creatinine; Cytokines; Double-Blind Method; Drug E | 2009 |
Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Double-Blin | 2009 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Contrast Media; Diabetes Complications; Double- | 2011 |
Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Cor | 2012 |
Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Cor | 2012 |
Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Cor | 2012 |
Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Cor | 2012 |
Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Double-Blind Method; Female; Free Radical | 2012 |
Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Chi-Square Distribution; Contrast Media; Coronary Angiogr | 2003 |
Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Angiography; Antioxidants; Cont | 2004 |
Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy.
Topics: Acute Kidney Injury; Angiography; Contrast Media; Coronary Angiography; Cost-Benefit Analysis; Healt | 2005 |
Incidence of contrast nephropathy in patients receiving comprehensive intravenous and oral hydration.
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Female; Fluid Therapy; Gl | 2005 |
Incidence of contrast nephropathy in patients receiving comprehensive intravenous and oral hydration.
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Female; Fluid Therapy; Gl | 2005 |
Incidence of contrast nephropathy in patients receiving comprehensive intravenous and oral hydration.
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Female; Fluid Therapy; Gl | 2005 |
Incidence of contrast nephropathy in patients receiving comprehensive intravenous and oral hydration.
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Female; Fluid Therapy; Gl | 2005 |
I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Biomarkers; Contrast Media; Creatinine; Cystatin C; Cyst | 2007 |
Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Iohexol | 2007 |
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.
Topics: Acute Kidney Injury; Aged; Angiocardiography; Diabetes Complications; Diatrizoate Meglumine; Double- | 1995 |
Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application.
Topics: Acute Kidney Injury; Adenosine; Aldosterone; Contrast Media; Creatinine; Double-Blind Method; Female | 1994 |
Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration.
Topics: Acetylglucosaminidase; Acute Kidney Injury; Aged; Albuminuria; Alpha-Globulins; Angiography, Digital | 1996 |
Enzyme markers of contrast media-induced renal failure.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Diatrizoate; Enzymes; Humans; Iohexol; Kidney | 1990 |
A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography.
Topics: Acute Kidney Injury; Aged; Angiography; Creatinine; Diabetes Mellitus; Double-Blind Method; Female; | 1990 |
116 other studies available for iohexol and Acute Kidney Failure
| Article | Year |
|---|---|
Metabolomic Study on Iohexol-Induced Nephrotoxicity in Rats Based on NMR and LC-MS Analyses.
Topics: Acute Kidney Injury; Animals; Chromatography, Liquid; Contrast Media; Injections, Subcutaneous; Iohe | 2022 |
A convenient online desalination tube coupled with mass spectrometry for the direct detection of iodinated contrast media in untreated human spent hemodialysates.
Topics: Acute Kidney Injury; Contrast Media; Hemodialysis Solutions; Humans; Iodine Compounds; Iohexol; Mass | 2022 |
Glomerular filtration rate in critically ill neonates and children: creatinine-based estimations versus iohexol-based measurements.
Topics: Acute Kidney Injury; Child; Creatinine; Critical Illness; Glomerular Filtration Rate; Humans; Infant | 2023 |
A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium.
Topics: Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Furosemide; Iohexol; Kidney; M | 2022 |
Kidney outcomes in early adolescence following perinatal asphyxia and hypothermia-treated hypoxic-ischaemic encephalopathy.
Topics: Acute Kidney Injury; Adolescent; Asphyxia; Asphyxia Neonatorum; Creatinine; Cysts; Female; Humans; H | 2023 |
Exploring the effects of edaravone in rats with contrast-induced acute kidney injury.
Topics: Acute Kidney Injury; Animals; Antioxidants; Biomarkers; Contrast Media; Creatinine; Edaravone; Gluta | 2022 |
Baicalin Alleviates Contrast-Induced Acute Kidney Injury Through ROS/NLRP3/Caspase-1/GSDMD Pathway-Mediated Proptosis in vitro.
Topics: Acute Kidney Injury; Caspase 1; Contrast Media; Cytokines; Exophthalmos; Flavonoids; Humans; Inflamm | 2022 |
An in vivo and in vitro model on the protective effect of cilnidipine on contrast-induced nephropathy via regulation of apoptosis and CaMKⅡ/mPTP pathway.
Topics: Acute Kidney Injury; Apoptosis; Atractyloside; Calcium-Calmodulin-Dependent Protein Kinase Type 2; C | 2023 |
Ox-LDL aggravates contrast-induced injury of renal tubular epithelial cells.
Topics: Acute Kidney Injury; Apoptosis; Epithelial Cells; Humans; Hypercholesterolemia; Iohexol; Lipoprotein | 2023 |
Iohexol-Measured Glomerular Filtration Rate and Urinary Biomarker Changes between Vancomycin and Vancomycin Plus Piperacillin-Tazobactam in a Translational Rat Model.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Biomarkers; Drug Therapy, Combination; Glomerul | 2023 |
Incomplete Recovery from the Radiocontrast-Induced Dysregulated Cell Cycle, Adhesion, and Fibrogenesis in Renal Tubular Cells after Radiocontrast (Iohexol) Removal.
Topics: Acute Kidney Injury; Apoptosis; Cell Cycle; Contrast Media; Fibrosis; Humans; Iohexol | 2023 |
Arginase2 mediates contrast-induced acute kidney injury via facilitating nitrosative stress in tubular cells.
Topics: Acute Kidney Injury; Animals; Apoptosis; Cisplatin; Humans; Iohexol; Kidney; Mice; Mice, Inbred C57B | 2023 |
Investigating the Possible Protective Role of Direct Intra-arterial Administration of Mannitol and N-Acetylcysteine and Per Os Administration of Simvastatin Against Contrast-Induced Nephropathy: An Experimental Study in a Rabbit Model.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Animals; Contrast Media; Disease Models, | 2019 |
Inhibition of xanthine oxidoreductase protects against contrast-induced renal tubular injury by activating adenosine monophosphate-activated protein kinase.
Topics: Acute Kidney Injury; AMP-Activated Protein Kinase Kinases; Animals; Antioxidants; Apoptosis; Contras | 2019 |
Contrast-Associated Acute Kidney Injury in Endovascular Thrombectomy Patients With and Without Baseline Renal Impairment.
Topics: Acute Kidney Injury; Aged; Case-Control Studies; Contrast Media; Creatinine; Endovascular Procedures | 2019 |
A novel rat model of contrast-induced nephropathy based on dehydration.
Topics: Acute Kidney Injury; Animals; Biomarkers; Contrast Media; Creatinine; Dehydration; Disease Models, A | 2019 |
DDAH-2 alleviates contrast medium iopromide-induced acute kidney injury through nitric oxide synthase.
Topics: Acute Kidney Injury; Amidohydrolases; Animals; Arginine; Cell Line; Contrast Media; Female; Humans; | 2019 |
Acetylbritannilactone attenuates contrast-induced acute kidney injury through its anti-pyroptosis effects.
Topics: Acute Kidney Injury; Animals; Apoptosis Regulatory Proteins; Cell Line; Disease Models, Animal; Epit | 2020 |
MG53 protects against contrast-induced acute kidney injury by reducing cell membrane damage and apoptosis.
Topics: Acute Kidney Injury; Animals; Apoptosis; Cell Membrane; Epithelial Cells; Female; Humans; Iohexol; K | 2020 |
Application of diffusion tensor imaging and blood oxygenation level-dependent magnetic resonance imaging to assess bilateral renal function induced by Iohexol in rabbits.
Topics: Acute Kidney Injury; Animals; Anisotropy; Blood Urea Nitrogen; Contrast Media; Creatinine; Cystatin | 2020 |
MicroRNA-30c attenuates contrast-induced acute kidney injury by suppressing NLRP3 inflammasome.
Topics: Acute Kidney Injury; Animals; Cells, Cultured; Contrast Media; Epithelial Cells; Inflammasomes; Iohe | 2020 |
Ferrotoxicity and Its Amelioration by Calcitriol in Cultured Renal Cells.
Topics: Acute Kidney Injury; Animals; Antioxidants; Calcitriol; Chlorocebus aethiops; Iohexol; Kidney; Lipid | 2021 |
Kinetic Glomerular Filtration Rate Equations in Patients With Shock: Comparison With the Iohexol-Based Gold-Standard Method.
Topics: Acute Kidney Injury; Aged; Creatinine; Glomerular Filtration Rate; Humans; Intensive Care Units; Ioh | 2021 |
Involvement of necroptosis in contrast-induced nephropathy in a rat CKD model.
Topics: Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Iohexol; Kidney Tubules, Proxi | 2021 |
Novel biomarkers for post-contrast acute kidney injury identified from long non-coding RNA expression profiles.
Topics: Acute Kidney Injury; Aged; Animals; Biomarkers; Contrast Media; Disease Models, Animal; Female; Gene | 2021 |
A nephroprotective iodinated contrast agent with cardioprotective properties: A pilot study.
Topics: Acute Kidney Injury; Animals; Contrast Media; Humans; Iohexol; Kidney; Male; Pilot Projects; Rats | 2021 |
Ascorbic acid ameliorates renal injury in a murine model of contrast-induced nephropathy.
Topics: Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Ascorbic Acid; Caspase 3; Contrast Media; Cre | 2017 |
Application of noninvasive functional imaging to monitor the progressive changes in kidney diffusion and perfusion in contrast-induced acute kidney injury rats at 3.0 T.
Topics: Acute Kidney Injury; Animals; Contrast Media; Diffusion Magnetic Resonance Imaging; Disease Progress | 2018 |
Serum Neutrophil Gelatinase-Associated Lipocalin and Urinary Kidney Injury Molecule-1 as Potential Biomarkers of Subclinical Nephrotoxicity After Gadolinium-Based and Iodinated-Based Contrast Media Exposure in Pediatric Patients with Normal Kidney Functio
Topics: Acute Kidney Injury; Adolescent; Biomarkers; Case-Control Studies; Child; Child, Preschool; Contrast | 2017 |
Predictors and Outcomes of Postcontrast Acute Kidney Injury after Endovascular Renal Artery Intervention.
Topics: Acute Kidney Injury; Aged; Computed Tomography Angiography; Contrast Media; Female; Follow-Up Studie | 2017 |
Effect of Atrial Fibrillation on Contrast-Induced Nephropathy Development in Patients With Non-ST-Segment Elevation Myocardial Infarction.
Topics: Acute Kidney Injury; Aged; Atrial Fibrillation; Contrast Media; Echocardiography; Female; Glomerular | 2017 |
Platelet-to-lymphocyte ratio predicts contrast-induced acute kidney injury in diabetic patients with ST-elevation myocardial infarction.
Topics: Acute Kidney Injury; Aged; Area Under Curve; Blood Platelets; Contrast Media; Coronary Angiography; | 2017 |
Continuous Infusion of Low-Dose Iohexol Measures Changing Glomerular Filtration Rate in Critically Ill Patients.
Topics: Acute Kidney Injury; Adult; Contrast Media; Glomerular Filtration Rate; Humans; Infusions, Intraveno | 2018 |
Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury.
Topics: Acute Kidney Injury; Animals; Apoptosis; Cell Line; Contrast Media; Enzyme Activation; Gene Silencin | 2018 |
Astaxanthin attenuates contrast agent-induced acute kidney injury in vitro and in vivo via the regulation of SIRT1/FOXO3a expression.
Topics: Acute Kidney Injury; Animals; Apoptosis; bcl-2-Associated X Protein; Blood Urea Nitrogen; Caspase 3; | 2018 |
Mitophagy Plays a Protective Role in Iodinated Contrast-Induced Acute Renal Tubular Epithelial Cells Injury.
Topics: Acute Kidney Injury; Adenine; Apoptosis; Autophagy; Cell Line; Contrast Media; Epithelial Cells; Hum | 2018 |
Comparison of iohexol and iodixanol induced nephrotoxicity, mitochondrial damage and mitophagy in a new contrast-induced acute kidney injury rat model.
Topics: Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Iohexol; Kidney Function Tests | 2018 |
Bilateral Sustained Nephrograms After Parenteral Administration of Iodinated Contrast Material: A Potential Biomarker for Acute Kidney Injury, Dialysis, and Mortality.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Biomarkers; Cardiac Catheterization; Contras | 2018 |
Postcontrast Acute Kidney Injury in Pediatric Patients: A Cohort Study.
Topics: Acute Kidney Injury; Adolescent; Child; Cohort Studies; Contrast Media; Female; Follow-Up Studies; H | 2018 |
Shadow over abdomen.
Topics: Abdominal Cavity; Acute Kidney Injury; Catheterization, Central Venous; Computed Tomography Angiogra | 2018 |
Involvement of organic cation transporter 2 in the metformin-associated increased lactate levels caused by contrast-induced nephropathy.
Topics: Acidosis, Lactic; Acute Kidney Injury; Animals; Cell Line; Contrast Media; Disease Models, Animal; H | 2018 |
Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Female; Humans; Incide | 2018 |
Caspase-11-mediated tubular epithelial pyroptosis underlies contrast-induced acute kidney injury.
Topics: Acute Kidney Injury; Animals; Caspases; Caspases, Initiator; Cells, Cultured; Contrast Media; Diseas | 2018 |
Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Catheterization; Cerebrovas | 2019 |
Negligible Risk of Acute Renal Failure Among Hospitalized Patients After Contrast-Enhanced Imaging With Iodinated Versus Gadolinium-Based Agents.
Topics: Acute Kidney Injury; Contrast Media; Female; Gadolinium; Humans; Inpatients; Iodine; Iohexol; Israel | 2019 |
Creatinine versus cystatin C based glomerular filtration rate in critically ill patients.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Creatinine; Critical Care; Critical Illness; | 2019 |
Renal Safety of Intra-Arterial Treatment after Acute Ischemic Stroke with Multimodal CT Imaging selection.
Topics: Acute Kidney Injury; Aged; Biomarkers; Brain Ischemia; Clinical Decision-Making; Contrast Media; Cre | 2019 |
Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Adult; Aged; Biomarkers; Cohort Studies; Contrast Media; | 2013 |
Anemia and the risk of contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT.
Topics: Acute Kidney Injury; Aged; Anemia; Causality; Comorbidity; Contrast Media; Drug-Related Side Effects | 2013 |
Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury.
Topics: Acute Kidney Injury; Apoptosis; Contrast Media; Humans; Iohexol; Iopamidol; Kidney; NADP; NADPH Oxid | 2014 |
Comparison of effects of isotonic sodium chloride with diltiazem in prevention of contrast-induced nephropathy.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Calcium Channel Blockers; | 2014 |
A novel rat model of contrast-induced acute kidney injury.
Topics: Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Iohexol; Male; Rats, Sprague-D | 2014 |
Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of Rho-kinase pathway.
Topics: Acute Kidney Injury; Animals; Apoptosis; Atorvastatin; bcl-2-Associated X Protein; Caspase 3; Contra | 2014 |
Evaluation of intrarenal oxygenation in iodinated contrast-induced acute kidney injury-susceptible rats by blood oxygen level-dependent magnetic resonance imaging.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Biomarkers; Contrast Media; Feasibility Studies; | 2014 |
Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker.
Topics: Acetylcysteine; Acute Kidney Injury; Acute-Phase Proteins; Animals; Biomarkers; Contrast Media; Dise | 2014 |
Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and com
Topics: Acute Kidney Injury; Analysis of Variance; Animals; Contrast Media; Diffusion Magnetic Resonance Ima | 2014 |
Extended renal outcomes with use of iodixanol versus iohexol after coronary angiography.
Topics: Acute Kidney Injury; Age Distribution; Aged; Cohort Studies; Contrast Media; Coronary Angiography; F | 2014 |
Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
Topics: Acute Kidney Injury; Aged; Contrast Media; Electronic Health Records; Female; Humans; Injections, In | 2014 |
Limb ischemic preconditioning protects against contrast-induced acute kidney injury in rats via phosphorylation of GSK-3β.
Topics: Acute Kidney Injury; Androstadienes; Animals; Apoptosis; Chromones; Contrast Media; Disease Models, | 2015 |
A novel contrast-induced acute kidney injury model based on the 5/6-nephrectomy rat and nephrotoxicological evaluation of iohexol and iodixanol in vivo.
Topics: Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Iohexol; Kidney; Male; Nephrec | 2014 |
Iohexol clearance for determination of glomerular filtration rate in rats induced to acute renal failure.
Topics: Acute Kidney Injury; Animals; Biomarkers; Cisplatin; Creatinine; Glomerular Filtration Rate; Inulin; | 2015 |
Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Occlusion; Female; Glomerular Filtration Rate; H | 2015 |
Intravenous contrast material and acute kidney injury: a need for caution.
Topics: Acute Kidney Injury; Contrast Media; Female; Humans; Iohexol; Male; Renal Dialysis; Triiodobenzoic A | 2015 |
Response.
Topics: Acute Kidney Injury; Contrast Media; Female; Humans; Iohexol; Male; Renal Dialysis; Triiodobenzoic A | 2015 |
Radiocontrast-induced nephropathy is attenuated by autophagy through regulation of apoptosis and inflammation.
Topics: Acute Kidney Injury; Adenine; Animals; Apoptosis; Autophagy; Cell Culture Techniques; Cell Line; Cel | 2016 |
No Association between Intravenous Contrast Material Exposure and Adverse Clinical Outcome: Are Prevention Protocols Effective?
Topics: Acute Kidney Injury; Contrast Media; Female; Humans; Iohexol; Male; Renal Dialysis; Triiodobenzoic A | 2015 |
Response.
Topics: Acute Kidney Injury; Contrast Media; Female; Humans; Iohexol; Male; Renal Dialysis; Triiodobenzoic A | 2015 |
The incidence and significance of acute kidney injury following emergent contrast administration in patients with STEMI and stroke.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Cohort Studies; Contrast Media; Creatinine; | 2016 |
A Retrospective Review of Contrast Nephropathy in a General Population.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Contrast Media; Creatinine; Female; Humans; Iohexol; I | 2015 |
Microalbuminuria in patients with preserved renal function as a risk factor for contrast-Induced acute kidney injury following invasive coronary angiography.
Topics: Acute Kidney Injury; Age Factors; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood | 2016 |
Iohexol clearance in unstable critically ill patients: a tool to assess glomerular filtration rate.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Creatinine; Critical Illness; Female; Glomerular Filtr | 2016 |
Preclinical Studies of a Kidney Safe Iodinated Contrast Agent.
Topics: Acute Kidney Injury; Animals; Apoptosis; beta-Cyclodextrins; Cell Line; Contrast Media; Disease Mode | 2016 |
Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Glomerular | 2016 |
Salvianolic Acid B Prevents Iodinated Contrast Media-Induced Acute Renal Injury in Rats via the PI3K/Akt/Nrf2 Pathway.
Topics: Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Benzofurans; Biomarkers; Cell Line, Tumor; Co | 2016 |
Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Topics: Acute Kidney Injury; Biomarkers; Blood Platelets; Contrast Media; Creatinine; Female; Humans; Iohexo | 2017 |
Circulating MicroRNA-188, -30a, and -30e as Early Biomarkers for Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Animals; Biomarkers; Circulating MicroRNA; Contrast Media; Disease Models, Anim | 2016 |
A retrospective evaluation of contrast-induced kidney injury in dogs (2006-2012).
Topics: Acute Kidney Injury; Animals; Contrast Media; Creatinine; Dog Diseases; Dogs; Female; Hospitals, Uni | 2016 |
Gender Difference in the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Humans; Incidence; Iohexol; | 2017 |
Augmented O-GlcNAc signaling via glucosamine attenuates oxidative stress and apoptosis following contrast-induced acute kidney injury in rats.
Topics: Acetylglucosamine; Acute Kidney Injury; Animals; Apoptosis; Contrast Media; Drug Evaluation, Preclin | 2017 |
Predictive Value of CHA2DS2-VASC Score for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography | 2017 |
Efficacy of oral supplemental hydration for the prevention of contrast-induced nephropathy in rats.
Topics: Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Fluid Therapy; Indomethacin; I | 2017 |
Contrast-induced acute kidney injury in renal transplant recipients after cardiac catheterization.
Topics: Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Creatinine; Female; Humans; Incidence; | 2009 |
Comment on meta-analyses of trials comparing contrast media.
Topics: Acute Kidney Injury; Aged; Cardiac Catheterization; Confidence Intervals; Contrast Media; Creatinine | 2009 |
Contrast-induced nephropathy after a second contrast exposure.
Topics: Acute Kidney Injury; Aged; Contrast Media; Female; Humans; Iohexol; Iopamidol; Male; Middle Aged; Pr | 2010 |
Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Topics: Acute Kidney Injury; Adult; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Disease Progressio | 2011 |
Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Topics: Acute Kidney Injury; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media | 2011 |
Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Databases, Factual; Female; Hospita | 2012 |
The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
Topics: Acute Kidney Injury; Animals; Biomarkers; Contrast Media; Iohexol; Kidney; Male; Mannitol; Osmolar C | 2012 |
Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.
Topics: Acute Kidney Injury; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme In | 2012 |
Effect of low-osmolar contrast medium iopromide and iso-osmolar iodixanol on DNA fragmentation in renal tubular cell culture.
Topics: Acute Kidney Injury; Cell Line; Contrast Media; DNA Fragmentation; Humans; Iohexol; Kidney; Osmolar | 2013 |
A randomized trial of prophylactic acetylcysteine and theophylline compared with placebo for the prevention of renal tubular vacuolization in rats after iohexol administration.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Contrast Media; Free Radical Scavengers; Iohexol; Kidn | 2003 |
Short- and long-term renal outcomes of immediate prophylactic hemodialysis after cardiovascular catheterizations in patients with severe renal insufficiency.
Topics: Acute Kidney Injury; Aged; Angina, Unstable; Cardiac Catheterization; Contrast Media; Coronary Angio | 2005 |
Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Female; Fluid Therapy; Humans; Iohexol; K | 2005 |
Comparison of renal damage by iodinated contrast or gadolinium in an acute renal failure rat model based on serum creatinine levels and apoptosis degree.
Topics: Acute Kidney Injury; Animals; Apoptosis; Contrast Media; Creatine; Female; Gadolinium DTPA; Iohexol; | 2005 |
The cost-effectiveness analysis (CEA) is dependent on the quality of the NEPHRIC study.
Topics: Acute Kidney Injury; Clinical Trials as Topic; Contrast Media; Cost-Benefit Analysis; Humans; Iohexo | 2006 |
A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo.
Topics: Acute Kidney Injury; Adenosine A1 Receptor Antagonists; Animals; Apoptosis; Cells, Cultured; Contras | 2006 |
Contrast-induced nephropathy in urgent coronary interventions.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; | 2006 |
[New aspects of contrast nephropathy in cardiology].
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Biomarkers; Contrast Media; Creatinine; Fluid Therapy; | 2007 |
[Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis].
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Cardiac Catheterization; Cohort Studies; Contrast Medi | 2007 |
Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
Topics: Acute Kidney Injury; Aged; Blood Flow Velocity; Contrast Media; Coronary Angiography; Creatinine; Fe | 2008 |
Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery.
Topics: Acute Kidney Injury; Age Factors; Aged; Cardiac Catheterization; Cardiac Surgical Procedures; Cardio | 2008 |
[Recurrent immune thrombocytopenia: a rare complication after contrast medium injection].
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Contrast Media; | 1995 |
Modulation of the renal effects of contrast media by endothelium-derived nitric oxide in the rat.
Topics: Acetylglucosaminidase; Acute Kidney Injury; Animals; Arginine; Creatinine; Iohexol; Ioxaglic Acid; K | 1993 |
Effects of femoral arteriography and low osmolar contrast agents on renal function.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Angiography; Contrast Media; Diabetes Mellitus; | 1993 |
Effects of contrast media on renal microcirculation and oxygen tension. An experimental study in the rat.
Topics: Acute Kidney Injury; Animals; Contrast Media; Diuretics; Erythrocyte Aggregation; Iohexol; Kidney; M | 1997 |
Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla.
Topics: Acute Kidney Injury; Animals; Contrast Media; Hypoxia; Injections, Intravenous; Iohexol; Ioxaglic Ac | 1998 |
Nephrotoxicity of high- and low-osmolar contrast media. The protective role of amlodipine in a rat model.
Topics: Acute Kidney Injury; Amlodipine; Analysis of Variance; Animals; Blood Urea Nitrogen; Calcium; Calciu | 2000 |
Contrast-medium-induced nephrotoxicity: are all answers in for acetylcysteine?
Topics: Acetylcysteine; Acute Kidney Injury; Combined Modality Therapy; Contrast Media; Double-Blind Method; | 2001 |
The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents.
Topics: Acute Kidney Injury; Animals; Contrast Media; Injections, Intravenous; Iohexol; Iopamidol; Kidney; L | 2002 |
Contrast media and regional renal blood flow. A study of the effects of ionic and non-ionic monomeric and dimeric contrast media in the rat.
Topics: Acute Kidney Injury; Animals; Contrast Media; Dehydration; Erythrocyte Aggregation; Glomerular Filtr | 1992 |
[Acute renal insufficiency after computer tomography with a low-osmolarity contrast agent].
Topics: Acute Kidney Injury; Aged; Female; Humans; Iohexol; Risk Factors; Tomography, X-Ray Computed | 1992 |
Contrast media-induced renal tubular vacuolization. A light and electron microscopic study on rat kidneys.
Topics: Acute Kidney Injury; Animals; Contrast Media; Diatrizoate; Female; Gadolinium DTPA; Iohexol; Kidney | 1991 |
Persistent CT nephrogram: significance in the diagnosis of contrast nephropathy--an update.
Topics: Acute Kidney Injury; Aged; Contrast Media; Diatrizoate; Female; Humans; Iohexol; Kidney; Kidney Cort | 1991 |
Nephrotoxicity of nonionic contrast media after cardiac angiography.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Angiocardiography; Cardiac Catheterization; Dos | 1989 |
Acute renal dysfunction in high-risk patients after angiography: comparison of ionic and nonionic contrast media.
Topics: Acute Kidney Injury; Adolescent; Aged; Aged, 80 and over; Angiography; Child; Contrast Media; Humans | 1989 |
Acute renal failure following low osmolality radiocontrast dye.
Topics: Acute Kidney Injury; Cardiac Catheterization; Female; Heart Failure; Heart Valve Diseases; Humans; I | 1988 |